蓝帆医疗跌2.14%，成交额4281.84万元，主力资金净流出1130.07万元

Core Viewpoint - Bluefan Medical's stock has experienced fluctuations, with a recent decline of 2.14% and a year-to-date increase of 15.79% [1][2] Financial Performance - For the period from January to June 2025, Bluefan Medical reported revenue of 2.781 billion yuan, a year-on-year decrease of 7.49%, while the net profit attributable to shareholders was -135 million yuan, an increase of 15.88% compared to the previous year [2] - Cumulative cash dividends since the A-share listing amount to 1.348 billion yuan, with 403 million yuan distributed over the last three years [2] Stock Market Activity - As of September 9, Bluefan Medical's stock price was 5.94 yuan per share, with a total market capitalization of 5.982 billion yuan [1] - The stock has seen a trading volume of 42.8184 million yuan and a turnover rate of 0.72% [1] - The stock's recent trading activity includes a net outflow of 11.3007 million yuan from major funds [1] Shareholder Information - As of August 20, the number of shareholders for Bluefan Medical increased to 78,900, with an average of 12,669 circulating shares per person, a decrease of 2.74% [2] - Hong Kong Central Clearing Limited is the third-largest circulating shareholder, holding 16.8348 million shares, an increase of 1.1296 million shares from the previous period [2] Business Overview - Bluefan Medical, established on December 2, 2002, and listed on April 2, 2010, operates primarily in cardiovascular, health protection, and emergency care sectors [1] - The revenue composition of the company includes health protection products (70.08%), cardiovascular products (24.88%), emergency rescue products (3.72%), and others (1.32%) [1] - The company is classified under the pharmaceutical and biological industry, specifically in medical devices and consumables [1]